Sycamore nears Boots sale after Walgreens Boots Alliance stock goes private

Sycamore Partners is nearing a potential Boots sale after Walgreens Boots Alliance stock went private. On September 30, 2026, Investing.com reported that Sycamore was close to an agreement to sell the U.K. pharmacy chain for approximately USD 9.00 billion including debt. GuruFocus reported that Sycamore acquired Walgreens earlier in 2026 for USD 23.70 billion.

Boots becomes the key transaction

The prospective transaction would separate one of Walgreens Boots Alliance's best-known international assets from the U.S. pharmacy operation. Investing.com said the buyer discussions involve the Canadian arm of the Weston family and that the deal could be finalized in the coming weeks if negotiations continue successfully.

The structure highlights the strategic logic of the take-private deal. Sycamore divided the acquired company into five units to facilitate potential sales of noncore operations, with Boots among the assets prepared for a possible disposal.

Scale remains substantial

The company investor-relations page lists 8,000 locations, 211,000 team members and 9 million daily customers. It also says 78 percent of Americans live within 5 miles of a Walgreens, giving the U.S. pharmacy network a measurable reach across the country.

That operating scale contrasts with the narrower public-market identity implied by the old WBA listing. The investor-relations page describes the current strategy as a return to core U.S. community pharmacy operations, with simplified processes and a stronger emphasis on pharmacy services.

Valuation reflects the restructuring

GuruFocus reported a price-to-sales ratio of 0.07 against a historical median of 0.34. The same analysis described negative earnings and said earnings-based valuation measures were not meaningful for the business during its restructuring.

For market observers, the Boots negotiations therefore provide a concrete test of the breakup strategy: a potential USD 9.00 billion disposal would be measured against the USD 23.70 billion acquisition value, while the remaining Walgreens operation is being repositioned outside public-market trading.

Private ownership sets the framework

CorpDigest states that WBA shares ceased trading on Nasdaq after the Sycamore transaction and that Walgreens became a private standalone pharmacy operator. The Boots sale talks are the latest visible step in that ownership model.

More news and analyses on Walgreens Boots Alliance stock